Altered sodium intake affects plasma concentrations of BNP but not proBNP in healthy individuals and patients with compensated heart failure

European Heart Journal

Volumn 28, Issue 22, 2007, Pages 2726-2731

  Damgaard, Morten ^a,b   Goetze, Jens Peter ^a   Norsk, Peter ^c   Gadsbøll, Niels ^b,d  

^a Rigshospitalet   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d KØGE HOSPITAL   (Denmark)

Author keywords

Plasma volume; Posture; Variability

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BODY POSTURE; CLINICAL ARTICLE; CONTROLLED STUDY; HEART FAILURE; HUMAN; MALE; PLASMA VOLUME; PRIORITY JOURNAL; SODIUM INTAKE; SODIUM URINE LEVEL; STEADY STATE; URINARY EXCRETION;

BIOLOGICAL MARKERS; CROSS-OVER STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PLASMA VOLUME; POSTURE; SODIUM CHLORIDE, DIETARY;

EID: 36248992789     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm396     Document Type: Article

References (27)

1. Goetze JP. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 2004;50:1503- 1510.
2. Cowie MR, Struthers AD, Wood DA, Coats AJS, Thompson SG, PooleWilson PA, Sutton GC. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-1353.
3. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-1130.
4. Bruins S, Fokkema MR, Romer JWP, DeJongste MJL, Van der Dijs FPL, Van den Ouewland JMW, Muskiet FAJ. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004;50:2052-2058.
5. Wu AHB, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003;92:628-631.
6. Pagani F, Stefini F, Panteghini M. Biological variation in serum concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP). Clin Chem 2003;49:A34.
7. La Villa G, Vena S, Conti A, Fronzaroli C, Brat A, Lazzeri C, Guerra T, Madiai S, Marra N, Franchi F. Plasma-levels of brain natriuretic peptide in healthy-subjects and patients with essential hypertension: response to posture. Clin Sci (Lond) 1993;85:411-416.
8. Selvais PL, Rousseau LJ, Ahn SA, Van Linden F, Ketelslegers JM, Rousseau MF. Usefulness of the supine-rest maneuver before neurohormonal sampling. Am J Cardiol 2002;89:772-774.
9. Lang CC, Coutie WJ, Khong TK, Choy AM, Struthers AD. Dietary sodium loading increases plasma brain natriuretic peptide levels in man. J Hypertens 1991;9:779-782.
10. Wambach G, Koch J. BNP plasma levels during acute volume expansion and chronic sodium loading in normal men. Clin Exp Hypertens 1995;17:619-629.
11. Wilkins MA, Su XL, Palayew MD, Yamashiro Y, Rolli P, Mckenzie JK, Kryger MH. The effects of posture change and continuous positive airway pressure on cardiac natriuretic peptides in congestive heart failure. Chest 1995;107:909-915.
12. Alvelos M, Ferreira A, Bettencourt P, Serrao P, Pestana M, Cerqueira-Gomes M, Soares-Da-Silva P. The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure. Eur J Heart Fail 2004;6:593-599.
13. Volpe M, Magri P, Rao MA, Cangianiello S, DeNicola L, Mele AF, Memoli B, Enea I, Rubattu S, Gigante B, Trimarco B, Epstein M, Condorelli M. Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition. Hypertension 1997;30:168-176.
14. Damgaard M, Norsk P, Gustafsson F, Kanters JK, Christensen NJ, Bie P, Friberg L, Gadsboll N. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 2006;290:R1294-R1301.
15. Intersalt Cooperation Research Group. Intersalt - an international study of electrolyte excretion and blood-pressure - results for 24 h urinary sodium and potassium excretion. BMJ 1988;297:319-328.
16. Wu AHB, Packer M, Smith A, Bijou R, Fink D, Mair J, Wallentin L, Johnson N, Feldcamp CS, Haverstick DM, Ahnadi CE, Grant A, Despres N, Bluestein B, Ghani F. Analytical and clinical evaluation of the Bayer ADVIA centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004;50:867-873.
17. Goetze JP, Kastrup J, Pedersen F, Rehfeld JF. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 2002;48:1035-1042.
18. Buckley MG, Markandu ND, Sagnella GA, MacGregor GA. Brain and atrial natriuretic peptides: a dual peptide system of potential importance in sodium balance and blood pressure regulation in patients with essential hypertension. J Hypertens 1994;12:809-813.
19. Heer M, Baisch F, Kropp J, Gerzer R, Drummer C. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol 2000;278:F585-F595.
20. Kjaer A, Appel J, Hildebrandt P, Petersen CL. Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects. Eur J Heart Fail 2004;6:29-39.
21. Bentzen H, Pedersen RS, Nyvad O, Pedersen EB. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure. Int J Cardiol 2004;93:121-130.
22. Sheth T, Parker T, Block A, Hall C, Adam A, Pfeffer MA, Stewart DJ, Qian CL, Rouleau JL. Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure. Am J Cardiol 2002;90:496-500.
23. Fung JWH, Yu CM, Yip G, Chan S, Yandle TG, Richards AM, Nicholls MG, Sanderson JE. Effect of beta blockade (Carvedilol or metoprolol) on activation of the renin-angiotensin-aidosterone system and natriuretic peptides in chronic heart failure. Am J Cardiol 2003;92:406-410.
24. Rousseau MF, Gurne O, Duprez D, Van Mieghem W, Robert A, Ahn S, Galanti L, Ketelslegers JM. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal sub-study. J Am Coll Cardiol 2002;40:1596-1601.
25. Pemberton CJ, Johnson ML, Yandle TG, Espiner EA. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 2000;36:355-359.
26. Clerico A, Zucchelli GC, Pilo A, Passino C, Emdin M. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin Chem Lab Med 2006;44:366-378.
27. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls G, Richards M. Plasma amino-terminal B-type natriuretic peptide measured by Elecsys 2010 assay in a trial of hormone-guided treatment for heart failure. Clin Chem 2003;49:1212-1215.